Viridian Therapeutics, Inc. (NASDAQ:VRDN) Q1 2024 Earnings Call Transcript May 8, 2024
Viridian Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.00079, expectations were $-1.07. VRDN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Welcome to the Viridian Therapeutics First Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a...
